alendronate

(redirected from alendronate sodium)
Also found in: Dictionary, Medical.
Related to alendronate sodium: Risedronate sodium
Graphic Thesaurus  🔍
Display ON
Animation ON
Legend
Synonym
Antonym
Related
  • noun

Synonyms for alendronate

a tablet (trade name Fosamax) prescribed to prevent or treat osteoporosis in women after menopause

References in periodicals archive ?
Materials and methods: Between May 2006 and July 2006, 60 female Wistar Albino rats aged three months were randomly allocated to three groups: sham operated receiving no treatment (Shm); ovariectomized-alendronate receiving 1 mg/kg/day alendronate sodium (Ovx-A), and ovariectomized-vehicle receiving 1 mL/kg/day physiological saline (Ovx-PS).
By various mechanisms of action, alendronate sodium can enhance bone strength, alleviate and prevent osteoporosis, effectively reduce the risk of fracture in centrum, hip bone and other parts.
Food and Drug Administration (FDA) approved alendronate sodium for treatment to increase bone mass in men with osteoporosis.
21] showed that alendronate sodium significantly decreased intima-media thickness in the carotid artery during a one-year follow-up.
EX101 is a proprietary buffered effervescent dosage form of alendronate sodium administered once weekly for treatment of osteoporosis in postmenopausal women and to increase bone mass in men with osteoporosis.
EX101 is a proprietary buffered effervescent dosage form of alendronate sodium administered once weekly for prevention and treatment of osteoporosis in postmenopausal women and incensement of bone mass in men with osteoporosis.
40 Teva USA Alendronate Sodium 00093517144 $229,911,061
The empirical formula of alendronate sodium is C4H12NNaO7P2*3H2O and its formula weight is 325.
Tenders are invited for Alendronate Sodium Tab 70Mg
Contract awarded for alendronate sodium 2,026 igss code and / or alendronate, 70 mg tablet
Alendronate sodium is chemically described as (4-amino-1-hydroxybutylidene) bisphosphonic acid monosodium salt trihydrate.
Tenders are invited for Tablet/Capsule Alendronate Sodium - 35 Mg
103 Barr Alendronate sodium 00555072054 $112,542,896
PARIS -- Ipsen (ISIN:FR0010259150) (Paris:IPN) and MSD today announced the signing of a co-marketing agreement under which MSD will grant Ipsen the marketing rights in France for Adrovance(TM), a fixed combination of alendronate sodium and cholecalciferol (vitamin D3), indicated for the treatment of postmenopausal osteoporosis in patients at risk of vitamin D deficiency.
Tenders are invited for Supply of Tablet/Capsule Alendronate Sodium - 35 Mg